Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

C H Weaver

Showing results (41-50 of 53) with videos related to

Pageof 6
Sort By:
Cytotherapy|August 13, 2002
Breast tumor contamination of PBSC harvests: tumor depletion by positive selection of CD34(+) cellsJ Burgess, B Mills, M Griffith, et al.
Transfusion|October 6, 1997
Collection of peripheral blood progenitor cells after the administration of cyclophosphamide, etoposide, and granulocyte-colony-stimulating factor: an analysis of 497 patientsC H Weaver, L S Schwartzberg, R Birch, et al.
Bone Marrow Transplantation|January 7, 1998
High-dose chemotherapy and peripheral blood stem cell infusion in patients with non-Hodgkin's lymphoma: results of outpatient treatment in community cancer centersC H Weaver, L Schwartzberg, B Zhen, et al.
Bone Marrow Transplantation|June 1, 1997
Engraftment and outcomes of patients receiving myeloablative therapy followed by autologous peripheral blood stem cells with a low CD34+ cell contentC H Weaver, J Potz, J Redmond, et al.
Bone Marrow Transplantation|April 1, 1997
Induction, mobilization of peripheral blood stem cells (PBSC), high-dose chemotherapy and PBSC infusion in patients with untreated stage IV breast cancer: outcomes by intent to treat analysesC H Weaver, W H West, L S Schwartzberg, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|August 2, 2000
Multicenter phase II study to evaluate a 28-day regimen of oral fluorouracil plus eniluracil in the treatment of patients with previously untreated metastatic colorectal cancerS Mani, H Hochster, T Beck, et al.
Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation|June 1, 1997
Collection of peripheral blood stem cells following administration of paclitaxel, cyclophosphamide, and filgrastim in patients with breast and ovarian cancerC H Weaver, L S Schwartzberg, R Birch, et al.
Journal of Hematotherapy|May 23, 1998
A randomized trial of two doses of cyclophosphamide with etoposide and G-CSF for mobilization of peripheral blood stem cells in 318 patients with stage II-III breast cancerL S Schwartzberg, C H Weaver, R Birch, et al.
American Journal of Clinical Oncology|October 22, 1998
Sequential treatment including high-dose chemotherapy with peripheral blood stem cell support in patients with high-risk stage II-III breast cancer: outpatient administration in community cancer centersL S Schwartzberg, R Birch, W H West, et al.
Bone Marrow Transplantation|June 1, 1997
High-dose busulfan, melphalan, thiotepa and peripheral blood stem cell infusion for the treatment of metastatic breast cancerW I Bensinger, K S Schiffman, L Holmberg, et al.
Pageof 6

Showing results (41-50 of 53) with videos related to

Sort By:
Pageof 6
Cytotherapy|August 13, 2002
Breast tumor contamination of PBSC harvests: tumor depletion by positive selection of CD34(+) cellsJ Burgess, B Mills, M Griffith, et al.
Transfusion|October 6, 1997
Collection of peripheral blood progenitor cells after the administration of cyclophosphamide, etoposide, and granulocyte-colony-stimulating factor: an analysis of 497 patientsC H Weaver, L S Schwartzberg, R Birch, et al.
Bone Marrow Transplantation|January 7, 1998
High-dose chemotherapy and peripheral blood stem cell infusion in patients with non-Hodgkin's lymphoma: results of outpatient treatment in community cancer centersC H Weaver, L Schwartzberg, B Zhen, et al.
Bone Marrow Transplantation|June 1, 1997
Engraftment and outcomes of patients receiving myeloablative therapy followed by autologous peripheral blood stem cells with a low CD34+ cell contentC H Weaver, J Potz, J Redmond, et al.
Bone Marrow Transplantation|April 1, 1997
Induction, mobilization of peripheral blood stem cells (PBSC), high-dose chemotherapy and PBSC infusion in patients with untreated stage IV breast cancer: outcomes by intent to treat analysesC H Weaver, W H West, L S Schwartzberg, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|August 2, 2000
Multicenter phase II study to evaluate a 28-day regimen of oral fluorouracil plus eniluracil in the treatment of patients with previously untreated metastatic colorectal cancerS Mani, H Hochster, T Beck, et al.
Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation|June 1, 1997
Collection of peripheral blood stem cells following administration of paclitaxel, cyclophosphamide, and filgrastim in patients with breast and ovarian cancerC H Weaver, L S Schwartzberg, R Birch, et al.
Journal of Hematotherapy|May 23, 1998
A randomized trial of two doses of cyclophosphamide with etoposide and G-CSF for mobilization of peripheral blood stem cells in 318 patients with stage II-III breast cancerL S Schwartzberg, C H Weaver, R Birch, et al.
American Journal of Clinical Oncology|October 22, 1998
Sequential treatment including high-dose chemotherapy with peripheral blood stem cell support in patients with high-risk stage II-III breast cancer: outpatient administration in community cancer centersL S Schwartzberg, R Birch, W H West, et al.
Bone Marrow Transplantation|June 1, 1997
High-dose busulfan, melphalan, thiotepa and peripheral blood stem cell infusion for the treatment of metastatic breast cancerW I Bensinger, K S Schiffman, L Holmberg, et al.
Pageof 6